Adequan® and its maker Luitpold Pharmaceuticals, Inc. has a history of promoting equestrian endeavors that bring entertainment, support, and better horse health to the equestrian community. Earlier this year, Adequan signed on as the title sponsor of the Global Dressage Festival. This three-year, major sponsorship begins in 2013 and will extend through the 2015 show season.
Adequan for joint disease in horses
Adequan® and its maker Luitpold Pharmaceuticals, Inc. has a history of promoting equestrian endeavors that bring entertainment, support, and better horse health to the equestrian community.
Adequan® has been an enthusiastic sponsor of the FTI Consulting Winter Equestrian Festival (FTI WEF) for several years. In 2010, Adequan® increased their sponsorship at the FTI WEF to be a weekly sponsor, and now their presence will be furthered at the Global Dressage Festival.
Mark Bellissimo, CEO of Equestrian Sport Productions, stated, "We are thrilled to have Adequan® join us as title sponsor of the Adequan® Global Dressage Festival. They have been such a strong sponsor in equestrian sport for so many years and we are very grateful for their support. This major sponsorship will ensure that within three years, the Adequan® Global Dressage Festival will become the most significant dressage event in the world."
"Luitpold Pharmaceuticals, Inc., makers of Adequan® (polysulfated glycosaminoglycan) is extremely excited to be the title sponsor of the Adequan® Global Dressage Festival beginning in 2013 through 2015," said Allyn G. Mann, Senior Manager of the Animal Health Division at Luitpold Pharmaceuticals, Inc.
"This financial commitment to the Global Dressage Community, as well as our continued high level support of the FTI Consulting Winter Equestrian Festival,is another example of our unwavering support of the equestrian industry."
In addition to supporting the Global Dressage Festival, Adequan maker Luitpold Animal Health is also a proud sponsore of the Professional Association of Therapeutic Horsemanship International. Their generous contributions support instructors and equine specialists in mental health as they work with special needs children and adults to help them reach their potential.
This past year, Luitpold, the maker of Adequan, contributed their products and a scholarship for registration at the 2012 AAEP conference to volunteer veterinarian award winners who worked with each of the 11 PATH Intl. centers.
Luitpold Animal Health makes Adequan® i.m. (Polysulfated Glycosaminoglycan) the only FDA-Approved Disease Modifying Osteoarthritis Drug for horses. Adequan® i.m. is a pure proven performer that helps repair damaged joints. Veterinarians and horse owners have depended on Adequan® i.m. for 27 years to stop degenerative joint disease and get their horses performing again.